First long-acting HIV treatment Cabenuva approved by FDA as monthly shots- Technology News, Firstpost
First long-acting HIV treatment Cabenuva approved by FDA as monthly shots ViiV said the shot combo would cost $5,940 for an initial, higher dose and $3,960 per month afterward. Jan 22, 2021 10:58:33 IST US regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus. Thursday’s approval of the two-shot combo called Cabenuva is expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy. It’s a huge change from not long ago, when patient...